EQL Pharma AB (publ) appoints Anna Jönsson as permanent Chief Financial Officer (CFO). She will take up the post of CFO immediately. Anna Jönsson has previously been CFO of the listed companies Amniotics AB and Respiratorius AB. She also has extensive experience from an accounting firm. Emanuel Eriksson has been acting CFO since last spring until a long-term solution was in place and he will continue work with investments.